Abstract

FLORES CAJAL, Beatriz et al. Successful systemic fibrinolysis in a patient with Covid-19: Case report. Rev. colomb. anestesiol. [online]. 2021, vol.49, n.3, e601.  Epub June 12, 2021. ISSN 0120-3347.  https://doi.org/10.5554/22562087.e969.

The new coronavirus 2019-nCov or SARS-Cov-2 is responsible for the most important pandemic in the 21st century: the coronavirus disease (COVID-19).

The 2019-nCov infection elicits a hyper-coagulable state, conditioning a worse outcome in these patients. The pathophysiology of the exaggerated coagulation activation in these patients is still unknown, and probably involves several mechanisms, different from those involved in sepsis-associated coagulopathy.

This article discusses the case of a patient with no remarkable medical history, who after 7 days of fever, diarrhea and epigastric pain was diagnosed with COVID-19 bilateral pneumonia, further aggravated by severe Acute Respiratory Distress Syndrome. In this context, the patient experienced a massive acute pulmonary thromboembolism accompanied by an acute thrombus in the heart's right ventricle, leading to hemodynamic instability. For the first time in our center in these patients, systemic fibrinolysis was successfully performed, with resolution of the intracavitary thrombus and the acute hemodynamic shock.

Keywords : ARDS; COVID-19; Coagulopathy; Fibrinolysis; Pulmonary thromboembolism; SARS-Cov-2.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )